BioCentriq will be attending Advanced Therapies USA 2024. Meet with our team to learn how we can accelerate your path to success and turn your breakthrough cell therapies into reality. Please fill out the form …

BioCentriq is proud to be a Platinum Sponsor at the Cell & Gene Meeting on the Mesa, one of the most influential conferences for the cell and gene therapy industry. This event brings together leaders …

BioCentriq’s Executive Director, Business Development, Chathuranga De Silva, Ph.D., will be attending Chardan’s 8th Annual Genetic Medicines Conference. Schedule a one-on-one meeting with him and learn all about BioCentriq as a collaborative CDMO by filling …

BioCentriq’s Executive Director, Business Development, Chathuranga De Silva, Ph.D., will be presenting at the Outsourced Pharma Capacity Update. Learn more about BioCentriq’s state-of-the-art facilities, established track record in GMP drug product release, and customized solutions …

BioCentriq will be attending the 6th Allogeneic Cell Therapies Summit. Meet with Executive Director of Business Development Chathuranga De Silva, Ph.D. to learn all about our capabilities as a global CDMO specializing in cell therapy. …

BioCentriq will be exhibiting at ISCT Vancouver 2024 with a company presentation, a poster and two panel discussions: • “Let’s Talk Particulates: Working Towards Best Practices,” presented by Mark Broadley, VP of Operations. • “End-to-end …

BioCentriq will be attending the ASGCT 27th Annual Meeting. We’ll be in Booth #539, where you can learn all about our capabilities as a global CDMO specializing in cell therapy. Please fill out the form …

BioCentriq will be attending Advanced Therapies Xchange San Diego 2024. Join Alex Klarer, VP of Strategy & Innovation in San Diego on Feb 29th! Discussion topics will cover Measuring Product Potency, Autologous C&G, Allogeneic Cell Therapies, …

BioCentriq will be attending the 7th CAR-TCR Summit Europe. Join David Smith, our VP of Development for the presentation of the first public CAR-T expansion data from BioCentriq’s collaboration with Terumo Blood and Cell Technologies. The data …

BioCentriq’s team will be attending and presenting at Phacilitate’s Advanced Therapies Week and will available for one-on-one meetings. Please contact us to schedule a meeting with the team.

BioCentriq will be attending the 65th ASH Annual Meeting and Exposition. Meet with Jennifer Manning, MPA, Chief Commercial Officer, and Chathuranga De Silva, Ph.D., Senior Director of Business Development to learn all about our capabilities as a …

Join BioCentriq, your go-to partner for turning breakthrough cell therapies into reality. As a collaborative CDMO, we’re all about amplifying your innovations in cell therapy and helping you get to patient faster. Meet our distinguished …